Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Kirk Randal J
Relationship:   10% Owner
City:   Radford
State:   VA
   
Insider Summary:
  
   
Companies Owned :   6    
Direct Shares   3,684,697    

Indirect Shares

   67,796,291      
Direct Value   $176,358,827    

Indirect Value

   $413,822,111      
Total Shares   71,480,988      
Total Value   $590,180,938      


Halozyme Therapeutics Inc $176,338,206 Alaunos Therapeutics $20,621 Halozyme Therapeutics Inc $176,338,206 Alaunos Therapeutics $20,621
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    14   
    0    

     Stock price went up :
    7   
    0    
     Stock price went down :
    7   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
   48.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Clinical Data Inc CLDA Director, 10% Owner 2011-04-12 0 2011-04-12 0    Premium*  
            Halozyme Therapeutics Inc HALO 10% Owner 2018-08-28 3,562,388 2018-08-28 6,629,464    Premium*  
            Precipio Inc PRPO 10% Owner 2012-02-03 0 2018-08-28 27,151    Premium*  
            Precigen Inc PGEN 0 2024-05-02 51,557,665    Premium*  
            Alaunos Therapeutics TCRT Director, 10% Owner 2015-12-31 122,309 2015-12-31 9,570,094    Premium*  
            Aquabounty Technologies, Inc. AQB 10% Owner 2020-02-13 0 2020-12-17 11,917    Premium*  
* Premium Members only  

Records found :    271         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 5 of 11
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
PGEN Precigen Inc Executive Chairman   •       •       •   2020-02-28 4 A $4.39 $200,057 I/I 45,571 22,730,215 0 -
PGEN Precigen Inc Chief Executive Officer   •       •       •   2019-04-30 4 A $4.56 $200,125 I/I 43,887 16,190,754 0 -
PGEN Precigen Inc Chief Executive Officer   •       •       •   2019-05-31 4 A $4.52 $200,159 I/I 44,283 17,946,829 0 -
PGEN Precigen Inc Chief Executive Officer   •       •       •   2014-05-09 4 B $13.42 $202,481 I/I 15,088 779,294 2.64 -
HALO Halozyme Therapeutics Inc Director   –       •       •   2007-09-19 4 B $9.00 $207,765 I/I 23,085 3,970,000 2.25 -
CLDA Clinical Data Inc Director   –       •       •   2006-08-28 4 B $15.07 $210,829 I/I 13,990 557,642 2.25 -
HALO Halozyme Therapeutics Inc Director   –       •       •   2008-06-18 4 B $5.76 $212,124 I/I 36,827 322,791 2.25 -
HALO Halozyme Therapeutics Inc 10% Owner   –       –       •   2006-08-17 4 B $2.46 $231,486 I/I 94,100 170,800 1.5 -
PGEN Precigen Inc Chief Executive Officer   •       •       •   2014-05-09 4/A B $13.42 $233,239 I/I 17,248 129,794 2.64 -
HALO Halozyme Therapeutics Inc 10% Owner   –       –       •   2006-08-24 4 B $2.50 $233,250 I/I 93,300 304,400 1.5 -
PGEN Precigen Inc Chief Executive Officer   •       •       •   2019-06-04 4 B $5.17 $233,270 I/I 45,120 1,078,323 2.64 -
HALO Halozyme Therapeutics Inc Director   –       •       •   2008-07-10 4 OE $1.75 $238,525 I/I 136,300 1,436,186 0 -
HALO Halozyme Therapeutics Inc 10% Owner   –       –       •   2007-03-14 4 B $7.91 $238,882 I/I 30,200 522,460 1.5 -
HALO Halozyme Therapeutics Inc Director   –       •       •   2008-06-17 4 B $5.98 $251,160 I/I 42,000 285,964 2.25 -
HALO Halozyme Therapeutics Inc Director   –       •       •   2008-06-13 4 B $5.53 $252,859 I/I 45,725 218,164 2.25 -
HALO Halozyme Therapeutics Inc 10% Owner   –       –       •   2006-09-15 4 B $2.50 $256,250 I/I 102,500 780,800 1.5 -
HALO Halozyme Therapeutics Inc 10% Owner   –       –       •   2006-08-25 4 B $2.50 $277,250 I/I 110,900 415,300 1.5 -
PGEN Precigen Inc Chief Executive Officer   •       •       •   2019-05-17 4 B $4.69 $283,886 I/I 60,530 858,125 2.64 -
PGEN Precigen Inc Chief Executive Officer   •       •       •   2019-05-21 4 B $4.74 $285,457 I/I 60,223 930,504 2.64 -
PGEN Precigen Inc Chief Executive Officer   •       •       •   2014-05-12 4 B $15.89 $287,069 I/I 18,066 797,360 2.64 -
HALO Halozyme Therapeutics Inc Director   –       •       •   2008-06-12 4 B $5.42 $308,940 I/I 57,000 172,439 2.25 -
PGEN Precigen Inc Chief Executive Officer   •       •       •   2019-05-24 4 B $4.68 $338,972 I/I 72,430 985,177 2.64 -
PGEN Precigen Inc Chief Executive Officer   •       •       •   2019-06-04 4 B $5.17 $349,900 I/I 67,679 154,803 2.64 -
HALO Halozyme Therapeutics Inc Director   –       •       •   2008-06-19 4 B $6.02 $360,598 I/I 59,900 382,691 2.25 -
HALO Halozyme Therapeutics Inc 10% Owner   –       –       •   2007-03-13 4 B $7.93 $365,414 I/I 46,080 1,308,080 1.5 -
  271  Records found
  1   2   3   4   5  6   7   8   9   10   11      
  Page 5 of 11  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us